These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25738967)

  • 21. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Antibacterial targets for the 21st century.
    Bugg TD
    Bioorg Chem; 2014 Aug; 55():1. PubMed ID: 24856786
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs for bad bugs: confronting the challenges of antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Pompliano DL
    Nat Rev Drug Discov; 2007 Jan; 6(1):29-40. PubMed ID: 17159923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between target-class and the physicochemical properties of antibacterial drugs.
    Mugumbate G; Overington JP
    Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective on the failures and successes of antibacterial drug discovery.
    Silver LL
    IDrugs; 2005 Aug; 8(8):651-5. PubMed ID: 16044374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The coming of age of antibiotics: discovery and therapeutic value.
    Bush K
    Ann N Y Acad Sci; 2010 Dec; 1213():1-4. PubMed ID: 21175674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Return of non-fluorinated quinolones: a novel landmark in the developing history of quinolone antimicrobial agents].
    He LX
    Zhonghua Nei Ke Za Zhi; 2020 Feb; 59(2):99-103. PubMed ID: 32074682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Microbial sensitivity to various antibacterials, including nalidixic acid. 2,458 Gram negative bacilli strains of diverse origins, especially urinary].
    Chamfeuil R; Curcier H
    Therapeutique; 1969 Oct; 45(8):757-62. PubMed ID: 5386084
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of six quinolone antibacterials (author's transl)].
    Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
    Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

  • 31. Quinolones in dermatology.
    Sable D; Murakawa GJ
    Dis Mon; 2004 Jul; 50(7):381-94. PubMed ID: 15280869
    [No Abstract]   [Full Text] [Related]  

  • 32. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
    Fernandes P; Pizza M
    Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
    [No Abstract]   [Full Text] [Related]  

  • 33. The Nobel Prize in physiology or medicine 100 years after Paul Ehrlich.
    Geddes A
    Int J Antimicrob Agents; 2009 Jan; 33(1):3. PubMed ID: 18926668
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland.
    Murray A; Mather H; Coia JE; Brown DJ
    J Antimicrob Chemother; 2008 Nov; 62(5):1153-5. PubMed ID: 18779257
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacteriophages, revitalized after 100 years in the shadow of antibiotics.
    Wei H
    Virol Sin; 2015 Feb; 30(1):1-2. PubMed ID: 25680442
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotics - quo vadit?].
    Lode HM; Stahlmann R
    Dtsch Med Wochenschr; 2012 Jun; 137(24):1314-6. PubMed ID: 22669701
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid-mediated quinolone resistance--current knowledge and future perspectives.
    Guan X; Xue X; Liu Y; Wang J; Wang Y; Wang J; Wang K; Jiang H; Zhang L; Yang B; Wang N; Pan L
    J Int Med Res; 2013 Feb; 41(1):20-30. PubMed ID: 23569126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolite concentration as a criterion for antibacterial discovery.
    Wang ZY; Zhu Q; Zhang HY
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):412-6. PubMed ID: 24010936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379.
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2009 Apr; 19(4):529-40. PubMed ID: 19441931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.